What MAOLAC does

MAOLAC is a privately held Israeli foodtech and biotechnology company headquartered in Tirat HaCarmel, Israel, founded in 2020/2021 by Maya Ashkenazi Otmazgin. The company develops and sells colostrum-based bioactive protein ingredients to B2B customers — primarily vitamin and supplement brands (e.g., Lemme), functional food and beverage formulators, and medical nutrition companies — rather than finished consumer products. It operates with a team of 11-50 employees and has raised approximately $5.6M in disclosed funding across seed and follow-on rounds led by OurCrowd and Mylkcubator. The company is certified to ISO 9001, halal, and kosher standards for its production facilities.

The company's core technology is the Maoreka™ AI-driven discovery platform, which uses computational biology, proteomics, and natural language processing to identify and extract functional proteins from bovine colostrum with high structural and functional similarity to human breast milk proteins. Its proprietary IgHM™ (human-compatible immune modulators) trademarked architecture replaces bovine IgG with protein domains that mirror human immune modulators, enabling claimed efficacy at 140-620 mg/day versus the 2-60 g/day typically required of standard colostrum. MAOLAC's branded product portfolio comprises four core ingredients: SuperColostrum™ (general wellness, 140 mg/day), MaolactinGI™ (gut health, 330-620 mg/day), MaolactinFMR™ (muscle recovery/mobility, 360 mg/day), and SuperColoSKN™ (skin health, launched 2026). COLOSTRUM 2.0 was launched in March 2026 for the clinical, practitioner, and premium formulation channel. Efficacy has been validated in randomized, double-blind, placebo-controlled human trials in Australia and Israel, with quantified outcomes including 35% reduction in GI symptom severity (GSRS, n=90), 38% reduction in indigestion, 52% reduction in bloating, 47% improvement in digestive quality of life, and a 900 U·h/L reduction in muscle damage markers in an 8-week trial (n=33).

MAOLAC operates a B2B ingredient sales model, generating revenue through ingredient supply agreements with brand and formulator customers. Distribution is handled through direct enterprise sales globally, supplemented by an exclusive North American distribution partnership with Caldic (announced February 2026, with commercial rollout planned for 2026). The company targets horizontal customer segments across gut health, muscle recovery, immunity, longevity, and skin health use cases. Its first flagship commercial brand partnership was with Lemme (Kourtney Kardashian Barker) in November 2025. The Scientific Advisory Board includes credentialed figures such as Dr. Michael Murray, Dr. Jacqueline Jacques, Dr. Sandra Einerhand, Prof. David C. Nieman, and Prof. Ilan Youngster.

Name

MAOLAC

Legal name

Maolac Ltd.

Website

https://maolac.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

11–50 employees

Short description

MAOLAC is an Israeli foodtech and biotechnology company that develops and sells clinically validated, AI-discovered colostrum-based bioactive protein ingredients to supplement brands, functional food formulators, and medical nutrition companies for gut, muscle, immune, and skin health applications.

Ownership category

akta.pro rank

Product category

Nutraceutical Ingredients

NAICS

Dairy Product Manufacturing (3115)

SIC

Dairy Products (2020)

akta.pro primary industry

Proteins & Functional Nutrition Ingredients (Plant/Animal Proteins, Collagen, Amino Acids) (CRADAOAJ)

akta.pro secondary industries

Animal-Derived Protein Ingredients (Egg, Collagen/Gelatin, Blood/Plasma Proteins) (AFAJAHAB), Amino Acids & Peptides (BCAAs, Collagen Peptides, Bioactive Peptides, L-Theanine) (AFAJAKAG)

Keywords

• Colostrum-based ingredients
• Bioactive protein ingredients
• Nutraceutical ingredients
• Functional food ingredients
• Dietary supplement ingredients

Headquarters

HQ city

Tirat Hakarmel

HQ country

Israel

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. B2B Ingredient Sales: Maolac develops and sells colostrum-based bioactive protein ingredients (SuperColostrum™, MaolactinGI™, MaolactinFMR™, SuperColoSKN™) to brands and formulators in the dietary supplement, functional food, beverage, and medical nutrition markets. Revenue is generated through ingredient supply agreements with brand partners.

Go-to-market motion3 records

Distribution channels2 records

Marketing channels7 records

Core offering

MAOLAC develops and sells colostrum-based bioactive protein ingredients (SuperColostrum™, MaolactinGI™, MaolactinFMR™, SuperColoSKN™) to supplement brands, functional food formulators, and medical nutrition companies. The company uses its proprietary Maoreka™ AI-driven proteomics platform to identify and extract proteins from bovine colostrum with high biosimilarity to human breast milk proteins, delivering clinically validated ingredients effective at 140-620 mg/day.

Product overview

MAOLAC is a deep tech biotechnology company that has developed a portfolio of colostrum-based biofunctional proteins inspired by human breast milk. The product portfolio consists of four main branded ingredients: SuperColostrum™ (general wellness, 140mg/day), MaolactinGI™ (gut health/microbiome, 330-620mg/day), MaolactinFMR™ (muscle recovery/mobility, 360mg/day), and SuperColoSKN™ (skin health, 2026 launch). All products are developed using the proprietary Maoreka™ AI-driven discovery platform that identifies and extracts functional proteins from bovine colostrum with high biosimilarity to human breast milk proteins. The company positions these as precision nutrition ingredients suitable for dietary supplements, functional foods, beverages, and medical nutrition applications.

Differentiator

Problem solved

Functional benefit

Brands

• SuperColostrum™: The first colostrum optimized for human biology, delivering a wide range of demonstrated health benefits in just 140mg per day.
• MaolactinGI™
• MaolactinFMR™
• SuperColoSKN™
• IgHM™
• Maoreka™

Products and services

• SuperColostrum™ The first colostrum optimized for human biology, delivering demonstrated health benefits in gut health, vitality, fitness, beauty, and digestion at just 140mg per day. Features over 20% IgHM™ bioactive content, 7x more effective than standard bovine colostrum, and contains no residual veterinary drugs, hormones, or antibiotics. For B2B ingredient customers developing dietary supplement and functional nutrition products.
• MaolactinGI™ A clinically proven colostrum-based bioactive protein ingredient that supports gut health, promotes balanced microbiome, and helps reduce bloating, constipation, and abdominal discomfort. Works at the biological root to support healthier gut environment with proven symptom alleviation at 330-620 mg/day. The first bio-biotic protein system that goes beyond prebiotics, probiotics, and postbiotics. For B2B supplement and functional food brand customers.
• MaolactinFMR™ A clinically validated colostrum-based ingredient for recovery, mobility, and healthy aging. Targets muscle damage and chronic low-grade inflammation (inflammaging) to support faster recovery, reduced soreness, and long-term mobility at just 360 mg/day. Backed by randomized double-blind, placebo-controlled clinical trial with 33 healthy active adults. For B2B sports nutrition, active nutrition, and healthy aging brand customers.
• SuperColoSKN™ Advanced colostrum designed specifically for human skin, delivering biofunctional proteins that support microbiome balance, inflammation control, and barrier function. Features 95%+ structural and functional similarity to human breast milk, 7x greater efficacy than generic colostrum, and 75%+ protein content. Targets anti-inflammatory action and skin resilience. For B2B skincare, beauty-from-within, and nutricosmetics brand customers.
• COLOSTRUM 2.0 AI-driven bovine colostrum ingredient that uses a proprietary 3D discovery platform to concentrate approximately 400 bioactive proteins with about 95% similarity to human biology. Designed for predictable microbiome modulation and clinically demonstrated digestive benefits at low daily doses. Targets clinical, practitioner, and premium formulation markets positioning for pharmaceutical-grade credibility.

Quantifiable outcome

• 35% reduction in overall gastrointestinal symptom severity (GSRS) in double-blind clinical trial (n=90)
• +11 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

Partnerships

Two partnerships are on record, tiered core and flagship.

• CaldiccoreChannel Partner/ Reseller/ Distributor · 19 February 2026Caldic, a global solutions provider for food and nutrition markets, partnered with Maolac to market and distribute Maolac's portfolio of colostrum-based ingredients across the North American nutrition sector. Products covered include Maolactin-GI, Maolactin-FMR, and Super Colostrum. Commercial rollout is planned for 2026. This is a key distribution partnership enabling Maolac to scale in the North American market.
• LemmeflagshipOEM/ Whitelabel/ Licensing Partner · 4 November 2025Lemme, a vitamin and supplement brand founded by Kourtney Kardashian Barker, launched new gut health products (Lemme Colostrum Gummies and Lemme Colostrum Liposomal Liquid) formulated with Maolac's scientifically-supported colostrum ingredient. The product launch received strong consumer response and was featured in leading business publications.

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Glanbia Nutritionals: Glanbia Nutritionals supplies whey proteins, milk proteins, and functional ingredient blends to supplement, performance, and food brands globally. It is a broad incumbent competing with Maolac in the dairy/functional-protein ingredient space with significantly greater scale and a wider customer base.
• Arla Foods Ingredients: Arla Foods Ingredients is a global dairy ingredient supplier (whey proteins, milk fractions, lactose) serving nutrition, health, and performance-food customers worldwide. It is a broad incumbent that competes with Maolac on the dairy-protein ingredients shelf and benefits from much deeper distribution and customer penetration.
• Kerry Group: Kerry Group is a global taste and nutrition ingredients platform serving food, beverage, and supplement customers. It competes with Maolac in bioactive and functional ingredient categories through its nutrition portfolio and has the scale and customer breadth to bundle Maolac-style innovations into larger accounts.
• ADM Nutrition: ADM's Nutrition segment is a global supplier of plant- and animal-protein ingredients, flavors, and health-and-wellness solutions for CPG and supplement brands. It is a broad incumbent that addresses the same brand customers as Maolac through protein-ingredient offerings.
• Hilmar Ingredients: Hilmar Ingredients is a US-based manufacturer of whey protein and dairy ingredient solutions for nutrition and food brands. As an established dairy-protein ingredient incumbent with strong US manufacturing capacity, it overlaps with Maolac's positioning on functional protein ingredients for nutrition customers.
• Cargill Health & Nutrition: Cargill supplies a broad portfolio of food and nutrition ingredients, including proteins and bioactives, to CPG and supplement manufacturers globally. It competes with Maolac in the functional-ingredient shelf and has the distribution network to reach every customer Maolac targets through Caldic and direct sales.
• International Flavors & Fragrances (IFF) Health & Biosciences: IFF's Health & Biosciences division produces probiotics, enzymes, and bioactive ingredients for nutrition and dietary-supplement brands. It is a broad incumbent with a microbial-protein discovery infrastructure that is adjacent and partially competitive with Maolac's AI-driven bioactive ingredient work.

Direct peers

• PanTheryx: PanTheryx is a US-based bovine colostrum ingredient supplier offering branded colostrum powders and formulations for immune and GI health to dietary-supplement and nutrition-brand customers. It is the closest direct competitor to Maolac in colostrum-based B2B ingredients targeting the same supplement and functional-food brand channels.
• APS Biogroup: APS Biogroup is a Switzerland-based manufacturer of hyperimmune bovine colostrum ingredients (including travelan/Colact/IMMUSE) for gut and immune health, sold primarily to dietary-supplement and functional-food brands. It directly competes with Maolac on colostrum-derived bioactive ingredients and pursues a similar B2B ingredient model.

Emerging players

• SternVitamin: SternVitamin is a premix and functional-ingredient supplier serving the European dietary-supplement and fortified-food industries. It is a smaller, ingredient-blending specialist whose customer base (vitamin and supplement brands) overlaps with Maolac's targeted B2B segments in functional nutrition formulations.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UC3YX8mqsuQZ_LEtPMsFk98w
• LinkedInlinkedin.com/company/maolac
• Instagraminstagram.com/maolac_ltd

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds4 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MAOLAC